Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Refractory Opportunistic Infection”

5 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 5 of 5 results

Large-scale testing (Phase 3)Ended earlyNCT00000730
What this trial is testing

Comparison of Three Treatments for Pneumocystis Pneumonia in AIDS Patients

Who this might be right for
Pneumonia, Pneumocystis CariniiHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 240
Testing effectiveness (Phase 2)Ended earlyNCT00005920
What this trial is testing

Safety and Effectiveness of Giving L-743,872 to Patients With Thrush That Has Not Been Cured With Fluconazole

Who this might be right for
Candidiasis, OralHIV Infections
Merck Sharp & Dohme LLC 70
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07579247
What this trial is testing

Efficacy and Safety of Immune Checkpoint Inhibitors for Refractory Opportunistic Infections in AIDS

Who this might be right for
HIVAIDSImmune Checkpoint Inhibitors+1 more
Shanghai Public Health Clinical Center 50
Very early researchLooking for participantsNCT03378102
What this trial is testing

Antigen Specific Adoptive T Cell Therapy for Adenovirus Infection After Hematopoietic Stem Cell Transplantation

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplantation
Mari Dallas 20
Not applicableStudy completedNCT00002181
What this trial is testing

Cidofovir as a Treatment for Herpes Simplex in Patients With AIDS

Who this might be right for
Herpes SimplexHIV Infections
Gilead Sciences